MAGLE — Magle Chemoswed Holding AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual income statement for Magle Chemoswed Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	132	146	170	236	283
Cost of Revenue
Gross Profit	111	134	154	222	232
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	127	133	152	213	410
Operating Profit	5.2	12.8	18	23.2	-127
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5.5	11	15.1	12.2	-163
Provision for Income Taxes
Net Income After Taxes	4.28	9.14	12.2	11.9	-160
Net Income Before Extraordinary Items
Net Income	4.28	9.14	12.2	11.9	-160
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4.28	9.14	12.2	11.9	-160
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.519	0.852	1.01	0.935	-7.74
Dividends per Share